Generation of PAX7 Reporter Cells to Investigate Skeletal Myogenesis from Human Pluripotent Stem Cells

This protocol describes the use of CRISPR/Cas9-mediated homology-directed recombination to construct a PAX7-GFP reporter in human pluripotent stem cells (hPSCs). PAX7 is a key transcription factor and regulator of skeletal muscle stem/progenitor cells. We obtained heterozygous knockin reporter cells...

Full description

Saved in:
Bibliographic Details
Published inSTAR protocols Vol. 1; no. 3; p. 100158
Main Authors Xi, Haibin, Young, Courtney S., Pyle, April D.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 18.12.2020
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This protocol describes the use of CRISPR/Cas9-mediated homology-directed recombination to construct a PAX7-GFP reporter in human pluripotent stem cells (hPSCs). PAX7 is a key transcription factor and regulator of skeletal muscle stem/progenitor cells. We obtained heterozygous knockin reporter cells and validated their PAX7 expression using both artificial activation by the CRISPR/dCas9-VPR system and physiological activation during hPSC myogenic differentiation. These cells can serve as tools for better understanding of in vitro hPSC myogenesis and enriching myogenic cells for downstream analysis. For complete details on the use and execution of this protocol, please refer to Xi et al. (2017) and Xi et al. (2020). [Display omitted] •Establish reporter hPSCs for myogenic transcription factor PAX7 via CRISPR/Cas9•Fast reporter validation by dCas9-VPR artificial activation of PAX7 promoter•Physiological reporter validation through hPSC directed myogenic differentiation This protocol describes the use of CRISPR/Cas9-mediated homology-directed recombination to construct a PAX7-GFP reporter in human pluripotent stem cells (hPSCs). PAX7 is a key transcription factor and regulator of skeletal muscle stem/progenitor cells. We obtained heterozygous knockin reporter cells and validated their PAX7 expression using both artificial activation by the CRISPR/dCas9-VPR system and physiological activation during hPSC myogenic differentiation. These cells can serve as tools for better understanding of in vitro hPSC myogenesis and enriching myogenic cells for downstream analysis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Lead Contact
Technical Contact
ISSN:2666-1667
2666-1667
DOI:10.1016/j.xpro.2020.100158